Training and Education

Angstrom Technology Awarded Best Cleanrooms Solutions Company 2024 at the International Life Sciences Awards

Global cleanroom solutions provider, Angstrom Technology has received the Best Cleanrooms Solutions Company Award at the International Life Sciences Awards 2024. GHP magazine’s International Life Sciences Awards programme recognises those that are going above and beyond, or indeed, the businesses...

Genetically engineered iPSCs offer improved efficiency and cost savings.

AMSBIO has launched a range of genetically engineered Induced Pluripotent Stem Cells (iPSCs) developed to provide improved model fidelity over cell lines and biochemical assays used for drug discovery and cell therapy research. These iPSC cell lines offer improved efficiency...

Sourcing, growing, and differentiating human skeletal muscle cells.

AMSBIO offers a wide range of products to support skeletal muscle cell culture enabling you to streamline your modelling process in vitro. Skeletal muscle accounts for 30-40% of the weight in a healthy individual. However, it is also a key...

Life Sciences SECTOR faceS ‘perfect storm’

Sector must work together to de-risk funding in medicines discovery and attract more investors, new study warns. A report by Medicines Discovery Catapult (MDC), in partnership with the UK BioIndustry Association and the Association of the British Pharmaceutical Industry, highlights...

Mission Genomics to launch the UK economy

UK-wide genetic testing will boost health, save lives, and create a new pathway for economic innovation, says Dr Stuart J. Grice, co-founder and CSO at FitnessGenes. The United Kingdom is at the forefront of genomics research. Initiatives like the UK...

Genes could ensure right sepsis treatment, faster

Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms. New research uncovers how different people respond to sepsis based on their genetic makeup, which could help identify who would benefit from certain treatments...

World-first generative AI tool designs enzymes for more sustainable industrial processes

ZymCTRL is the world’s first open-source, text-based enzyme generation model and can be used across multiple industries, including therapeutics and sustainability initiatives. The AI model can produce sequences that create functional enzymes with desirable characteristics for industrial applications. ZymCTRL (“enzyme...

First UK trial of Deep Brain Stimulation for children with epilepsy

A 13-year-old boy has made history as the first patient in the UK to take part in a clinical trial using deep brain stimulation (DBS) to treat epilepsy. Since the procedure, Oran’s daytime seizures have decreased by 80%, significantly improving...

Robotic ‘nerve cuffs’ could treat neurological conditions

Researchers have developed tiny, flexible devices that can wrap around individual nerve fibres without damaging them. Researchers from the University of Cambridge have combined flexible electronics and soft robotics techniques to develop the devices, which could be used for the...

Major milestone for North East Investment Zone at NETPark Phase 3

The £62million expansion of one of the UK’s premier science parks has taken a significant step towards completion. The Phase 3 development of the North East Technology Park (NETPark) at Sedgefield reached a major milestone as the last piece of...

Partnership to advance ALS research

A new collaboration is working to expand applications of DNA break-mapping technology and advance understanding of genomic instability in the development of neurodegenerative disease, amyotrophic lateral sclerosis. The research is being undertaken by Broken String Biosciences (“Broken String”), a genomics...

MONMOUTH SCIENTIFIC: Creating clean air through recirculating technology

At Monmouth Scientific, we are committed to providing solutions that foster a clean and sustainable environment. Our key innovation is the use of recirculating technology, enhanced by activated carbon and HEPA filtration. UNDERSTANDING RECIRCULATING TECHNOLOGY Recirculating technology involves the continuous movement...

UK drug companies ‘repeatedly violate marketing code’

New data analysis highlights potential “serious consequences” for patient health and lengthy complaint processing times. Research by University of Bath and Lund University academics reveals that public health in the UK could be undermined by a failing system of drug...

Initial in vivo validation of novel oncology therapeutic mechanism completed

Oxford Drug Design, an Oxford-based AI drug discovery company using an AI platform to develop novel molecules for use in cancer treatments, has successfully completed the first in vivo validation in its potential first-in-class approach against multiple tumours. The results...

Enzyme discovery paves way for greener cancer treatments

Scientists from The University of Manchester have uncovered a more efficient and sustainable way to make peptide-based medicines, showing promising effectiveness in combating cancers. Peptides are comprised of small chains of amino acids, which are also the building blocks of...

Trailblazing scientist is first British winner of Lifetime Achievement Award

British scientist Dame Carol Robinson has received the Lifetime Achievement Award at the European Inventor Award 2024. The Professor of Chemistry at the University of Oxford is a trailblazer in the field of mass spectrometry and has dedicated her career...

Scientists create tailored drug for aggressive breast cancer

Scientists have used breast cancer cells’ weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumours. The research, published in Clinical Cancer Research by a team from King’s College London and funded by Breast...

Chicken feathers to deliver chemotherapy drugs and repair enzymes

A new method of drug delivery using proline, an amino acid found in chicken feathers and skin tissue, could be used to limit the side effects of chemotherapy and repair important enzymes, new research suggests. Published in the journal Chem,...

Breakthrough in creating cyclic peptide opens the way for new antibiotics

A discovery by scientists at King’s College London could speed up efforts to produce new antibiotics in the fight against antimicrobial resistance. In a paper published in the Journal of the American Chemical Society, scientists from the Department of Chemistry...

How efficient logistics can change the lives of rare disease patients

Dr. Danial Arkwell, Head of Global Key Accounts, Pharma, at Envirotainer, highlights the vital role of efficient logistics in getting orphan drugs to patients in desperate need. There are approximately 8,000 rare diseases in the world, and many are life-threatening....

UK businesses must enforce ESG compliance in supply chains

New EU supply chain laws still impacting UK firms post-Brexit, and new standards mean UK healthcare and pharmaceutical companies can be legally liable for failure to comply, according to supply chain consultants, INVERTO. Most companies have already taken steps to...

Funding boost for UK pharma – how the Life Sciences Innovative Manufacturing Fund can help you

Karim Budabuss, Director of Grant Advisory, ForrestBrown, explains what firms need to know about funding eligibility and the application process.  As is the case for many sectors, inflation and high interest rates are increasing the cost of doing business in...

Bio-Britain: Kicking the UK’s fossil fuel habit with industrial biotechnology

Aline Miller, Professor of Biomolecular Engineering and Associate Dean of Business Engagement at The University of Manchester, explains how biotechnology can make the energy, manufacturing, and medical industries more sustainable. Given how inconceivably complex they are, the efficiency of most...

Biomedical leadership role for university researcher

Dr Antonio Fratini CEng MIMechE is the new chair of the Biomedical Engineering Division (BmED) of the Institution of Mechanical Engineers (IMechE), one of the largest groups of professional biomedical engineers in the UK. The IMechE has around 115,000 members...

High-performance temperature control for Biotechnology and Pharmaceutical engineering

We are LAUDA – the world leader in precise temperatures. Our constant temperature equipment and systems are at the heart of important applications, contributing to a better future.  As a full-service provider, we guarantee the optimum temperature in research, production...

New awards recognise innovation and excellence in STEM Marketing

Despite making up over 25% of the UK economy – equating to over £600bn - the STEM sector hasn’t had a dedicated marketing awards scheme...until now. A new awards scheme, which will celebrate outstanding communication campaigns and individual achievements for...

Safer AI research for engineering biology

Newly identified hazards in using data-centric methods to engineer biology will make research safer, say experts at the University of Bristol. The potential misuse of data-centric approaches in synthetic biology poses significant risk. The ease of access to data science...

AI learns to speak the language of cancer

A computer system using AI to learn the language of cancer can spot the signs of the disease in biological samples with remarkable accuracy, its developers say. An international team of AI specialists and cancer scientists are behind the breakthrough,...

AI ‘massively accelerates’ quest for Parkinson’s disease treatments

Researchers from the University of Cambridge designed and used an AI-based strategy to identify compounds that block the clumping, or aggregation, of alpha-synuclein, the protein that characterises Parkinson’s. The team used machine learning techniques to quickly screen a chemical library...

Healthcare regulators ‘must’ keep pace with AI advances

Head of Regulatory Affairs at InnoScot Health, Elaine Gemmell, analyses the current landscape. The ability of regulators to keep pace with artificial intelligence (AI) is vital if it is to play a successful role in exciting healthcare advancements, but also...